Indian-Origin Ex-CFO Jailed in US Healthcare Bribery Case
US court sentences Aditya Humad to four months in prison for conspiracy to pay surgeons illegal kickbacks
- Indian-origin former CFO Aditya Humad sentenced to four months in a US federal prison.
- Convicted of conspiring to pay over USD 540,000 in bribes disguised as consulting fees.
- Prosecutors said the scheme generated millions in revenue for SpineFrontier.
- Authorities recovered over USD 4 million through criminal and civil proceedings.
GG News Bureau
Washington, 11th Aug: An Indian-origin former chief financial officer of a US spinal implant company has been sentenced to four months in federal prison for conspiring to bribe surgeons with sham consulting fees to induce them to use the company’s medical devices.
The US District Court in Massachusetts sentenced Aditya Humad, 41, a resident of Cambridge, to four months’ imprisonment, followed by one year of supervised release and a USD 9,500 fine.
Humad had earlier pleaded guilty to one count of conspiracy to violate the federal anti-kickback statute. He was charged in September 2021 alongside Kingsley R. Chin, the founder, president and CEO of SpineFrontier.
According to the US Attorney’s Office for the District of Massachusetts, Humad conspired to pay and direct the payment of more than USD 540,000 in illegal kickbacks to surgeons in the guise of consulting fees for services they either did not perform or performed only minimally.
Prosecutors said the payments were intended to encourage surgeons to use SpineFrontier’s spinal implant products in surgeries, including procedures funded by Medicare, Medicaid and the Veterans Health Administration. The arrangement generated millions of dollars in revenue for the company.
The contracts purportedly compensated surgeons between USD 250 and USD 1,000 per hour for technical consulting. However, investigators alleged that many surgeons spent only a small fraction of the claimed hours—or none at all—providing legitimate consulting services.
US Attorney Leah B. Foley described the sentence as the culmination of years of investigation into the company, its executives and physicians involved in the scheme.
She said authorities have recovered more than USD 4 million from the executives, the company and the doctors through criminal and civil proceedings, adding that the case demonstrates the government’s commitment to tackling healthcare fraud.
Roberto Coviello, Special Agent in Charge at the US Department of Health and Human Services Office of Inspector General, said the bribery scheme undermined safeguards designed to protect patients and the integrity of taxpayer-funded healthcare programmes.
The investigation formed part of a broader crackdown by US authorities on illegal financial arrangements between medical device manufacturers and healthcare professionals.
